172 related articles for article (PubMed ID: 11490828)
1. Improvement of the prognosis of gastric cancer with extensive serosal invasion using left upper abdominal evisceration.
Isozaki H; Tanaka N; Fujii K; Tanigawa N; Okajima K
Hepatogastroenterology; 2001; 48(40):1179-82. PubMed ID: 11490828
[TBL] [Abstract][Full Text] [Related]
2. Postoperative results of left upper abdominal evisceration for advanced gastric cancer.
Yonemura Y; Kawamura T; Nojima N; Bandou E; Keizou T; Fujita H; Michiwa Y; Fujimura T; Fushida S; Ajisaka H; Miwa K
Hepatogastroenterology; 2000; 47(32):571-4. PubMed ID: 10791241
[TBL] [Abstract][Full Text] [Related]
3. [Left upper abdominal evisceration for advanced gastric cancer].
Oyama S; Nakajima T; Ota K; Ishihara S; Wakabayashi K; Nishi M
Gan To Kagaku Ryoho; 1994 Aug; 21(11):1781-6. PubMed ID: 8080296
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of macroscopic serosal invasion in advanced gastric cancer.
Yasuda K; Shiraishi N; Inomata M; Shiroshita H; Izumi K; Kitano S
Hepatogastroenterology; 2007; 54(79):2028-31. PubMed ID: 18251153
[TBL] [Abstract][Full Text] [Related]
5. Serosal invasion as the single prognostic indicator in stage IIIA (T3N1M0) gastric cancer.
Abe S; Shiraishi M; Nagaoka S; Yoshimura H; Dhar DK; Nakamura T
Surgery; 1991 May; 109(5):582-8. PubMed ID: 2020903
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection.
Shirabe K; Shimada M; Matsumata T; Higashi H; Yakeishi Y; Wakiyama S; Ikeda Y; Ezaki T; Fukuzawa S; Takenaka K; Kishikawa K; Ikeda T; Taguchi K; Maehara Y; Sugimachi K
Hepatogastroenterology; 2003; 50(53):1560-3. PubMed ID: 14571786
[TBL] [Abstract][Full Text] [Related]
7. Is bursectomy necessary for patients with gastric cancer invading the serosa?
Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Hasegawa S; Ishiwa N; Morinaga S; Noguchi Y; Yamamoto Y; Matsumoto A
Hepatogastroenterology; 2004; 51(59):1524-6. PubMed ID: 15362792
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intraperitoneal and intravenous chemotherapy and left upper abdominal evisceration for advanced gastric cancer.
Nomura E; Niki M; Fujii K; Shinohara H; Nishiguchi K; Sonoda T; Tanigawa N
Gastric Cancer; 2001; 4(2):75-82. PubMed ID: 11706764
[TBL] [Abstract][Full Text] [Related]
9. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategy for scirrhous type gastric cancer.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
Hepatogastroenterology; 2005; 52(61):314-8. PubMed ID: 15783058
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment for advanced carcinoma of the gastric remnant.
Isozaki H; Tanaka N; Fujii K; Nomura E; Tanigawa N
Hepatogastroenterology; 1998; 45(23):1896-900. PubMed ID: 9840172
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of the width of subserosal invasion in gastric cancer invading the subserosal layer.
Soga K; Ichikawa D; Yasukawa S; Kubota T; Kikuchi S; Fujiwara H; Okamoto K; Ochiai T; Sakakura C; Kokuba Y; Yanagisawa A; Otsuji E
Surgery; 2010 Feb; 147(2):197-203. PubMed ID: 19758672
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic factors in gastric cancer with serosal invasion--importance of the extent of cancer infiltration in the subserosal layer].
Habu H; Kando F; Saito N; Takeshita K; Sunagawa M; Endo M
Gan No Rinsho; 1989 May; 35(6):685-9. PubMed ID: 2724547
[TBL] [Abstract][Full Text] [Related]
14. Prognostic studies on gastric cancer with concomitant liver metastases.
Fujisaki S; Tomita R; Nezu T; Kimizuka K; Park E; Fukuzawa M
Hepatogastroenterology; 2001; 48(39):892-4. PubMed ID: 11462950
[TBL] [Abstract][Full Text] [Related]
15. [Results of left upper abdominal evisceration (LUAE) in diffuse infiltrating carcinoma of the stomach].
Ohta K; Nishi M; Nakajima T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1249-55. PubMed ID: 3382198
[TBL] [Abstract][Full Text] [Related]
16. Modified radical lymphadenectomy without splenectomy in patients with proximal gastric cancer: comparison with standard D2 lymphadenectomy for distal gastric cancer.
Cheong O; Kim BS; Yook JH; Oh ST; Park YK; Ryu SY
J Surg Oncol; 2008 Dec; 98(7):500-4. PubMed ID: 18770520
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.
Yonemura Y; de Aretxabala X; Fujimura T; Fushida S; Katayama K; Bandou E; Sugiyama K; Kawamura T; Kinoshita K; Endou Y; Sasaki T
Hepatogastroenterology; 2001; 48(42):1776-82. PubMed ID: 11813623
[TBL] [Abstract][Full Text] [Related]
18. A new surgical technique (left upper abdominal evisceration) for advanced carcinoma of the gastric stump.
Yonemura Y; Sugiyama K; Fujimura T; Kamata T; Sawa T; Takashima T; Ninomiya I; Fonseca L; Tsugawa K; Matsumoto H
Hepatogastroenterology; 1994 Apr; 41(2):130-3. PubMed ID: 8056399
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy with CDDP and 5-fluorouracil for gastric cancer with serosal invasion.
Takiguchi N; Nunomura M; Koda K; Oda K; Suzuki H; Miyazaki M
Oncol Rep; 2003; 10(2):433-8. PubMed ID: 12579285
[TBL] [Abstract][Full Text] [Related]
20. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer.
Yamamoto M; Baba H; Kakeji Y; Endo K; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Maehara Y
Hepatogastroenterology; 2004; 51(55):298-302. PubMed ID: 15011889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
